Corise Pimocard Plus 2.5mg is an advanced, prescription-only veterinary cardiac medication engineered for the comprehensive management of congestive heart failure (CHF), atrioventricular valvular insufficiency (AVVI), and Myxomatous Mitral Valve Disease (MMVD) in dogs. This innovative formulation introduces a specialized triple-action matrix consisting of Pimobendan (2.5mg), Benazepril Hydrochloride (5mg), and Coenzyme Q10 (10mg) to deliver robust multi-organ defense.

Pimobendan functions as an inodilator, sensitizing cardiac myofilaments to calcium to boost heart contraction force while dilating peripheral pathways to minimize systemic resistance. Simultaneously, Benazepril Hydrochloride works as an ACE inhibitor, relaxing constricted vessels, lowering blood pressure, and preventing adverse tissue remodeling. To enhance this therapeutic process, Coenzyme Q10 provides vital cellular energy ($ATP$) to the myocardium and acts as a powerful antioxidant to reduce oxidative stress. Beyond critical cardiac support, Pimocard Plus offers vital end-organ protection for the kidneys, liver, brain, and eyes, making it an exceptional long-term therapy for dogs experiencing concurrent chronic kidney disease (CKD).